‘Sec. 1. 22 MRSA §7250, sub-§4, ¶D, as enacted by PL 2003, c. 483, §1, is amended to read:
D. A patient to whom a prescription is written, insofar as the information relates to that patient; and
Sec. 2. 22 MRSA §7250, sub-§4, ¶E, as enacted by PL 2003, c. 483, §1, is amended to read:
E. Office personnel or personnel of any vendor or contractor, as necessary for establishing and maintaining the program's electronic system . ; and
Sec. 3. 22 MRSA §7250, sub-§4, ¶F is enacted to read:
F. The office that administers the MaineCare program pursuant to chapter 855 for the purposes of managing the care of its members, monitoring the purchase of controlled substances by its members and avoiding duplicate dispensing of controlled substances.’